Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study.

Autor:	Kudo T; Department of Radioisotope Medicine, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan., Lahey R; Seymour, Paul and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA., Hirschfeld CB; Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA., Williams MC; BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom., Lu B; National Center for Cardiovascular Diseases, Beijing, China., Alasnag M; Catheterization Laboratory, Cardiac Center, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia., Bhatia M; Department of Radiology and Imaging, Fortis Escorts Heart Institute, New Delhi, India., Henry Bom HS; Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, Jeonnam, South Korea., Dautov T; Department of Radiology, National Research Cardiac Surgery Center, Astana, Kazakhstan., Fazel R; Division of Cardiology, Department of Medicine, Masih Daneshvari Hospital, Tehran, Iran.; Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Karthikeyan G; All India Institute of Medical Sciences, New Delhi, India., Keng FYJ; Department of Cardiology, National Heart Centre Singapore, Singapore., Rubinshtein R; Department of Cardiology, Edith Wolfson Medical Center, Holon and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Better N; Departments of Nuclear Medicine and Cardiology, Royal Melbourne Hospital and University of Melbourne, Australia., Cerci RJ; Quanta Diagnóstico e Terapia, Curitiba, Brazil., Dorbala S; Division of Nuclear Medicine, Department of Radiology, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Raggi P; Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada., Shaw LJ; Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York, USA., Villines TC; University of Virginia, Charlottesville, Virginia, USA., Vitola JV; Quanta Diagnóstico e Terapia, Curitiba, Brazil., Choi AD; Division of Cardiology and Department of Radiology, The George Washington University School of Medicine, Washington, DC, USA., Malkovskiy E; Seymour, Paul and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.; Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.; Columbia College, Columbia University, New York, New York, USA., Goebel B; Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York, USA., Cohen YA; Technion American Medical School, Technion-Israel Institute of Technology, Haifa, Israel., Randazzo M; Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA., Pascual TNB; Philippine Nuclear Research Institute, Quezon City, Philippines., Pynda Y; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Dondi M; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Paez D; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Einstein AJ; Seymour, Paul and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.; Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.; Department of Radiology, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
Jazyk:	angličtina
Zdroj:	JACC. Asia [JACC Asia] 2021 Sep 21; Vol. 1 (2), pp. 187-199. Date of Electronic Publication: 2021 Sep 21 (Print Publication: 2021).
DOI:	10.1016/j.jacasi.2021.06.002
Abstrakt:	Background: The coronavirus disease-2019 (COVID-19) pandemic significantly affected management of cardiovascular disease around the world. The effect of the pandemic on volume of cardiovascular diagnostic procedures is not known. Objectives: This study sought to evaluate the effects of the early phase of the COVID-19 pandemic on cardiovascular diagnostic procedures and safety practices in Asia. Methods: The International Atomic Energy Agency conducted a worldwide survey to assess changes in cardiovascular procedure volume and safety practices caused by COVID-19. Testing volumes were reported for March 2020 and April 2020 and were compared to those from March 2019. Data from 180 centers across 33 Asian countries were grouped into 4 subregions for comparison. Results: Procedure volumes decreased by 47% from March 2019 to March 2020, showing recovery from March 2020 to April 2020 in Eastern Asia, particularly in China. The majority of centers cancelled outpatient activities and increased time per study. Practice changes included implementing physical distancing and restricting visitors. Although COVID testing was not commonly performed, it was conducted in one-third of facilities in Eastern Asia. The most severe reductions in procedure volumes were observed in lower-income countries, where volumes decreased 81% from March 2019 to April 2020. Conclusions: The COVID-19 pandemic in Asia caused significant reductions in cardiovascular diagnostic procedures, particularly in low-income countries. Further studies on effects of COVID-19 on cardiovascular outcomes and changes in care delivery are warranted. Competing Interests: This work was supported by the International Atomic Energy Agency (IAEA). The INCAPS-COVID study was led by the IAEA, which provided the required infrastructure for data collection. Information from participating centers was provided on a voluntary basis and no compensation was paid. The IAEA covers the cost of open access of any published manuscript. Dr Kudo has received consulting fees from Nihon mediphysics and FUJIFILM Toyama Chemical; and his institution has received grants from Nihon mediphysics and FUJIFILM Toyama Chemical, all unrelated to the current work. Dr Dorbala has received honoraria from Pfizer and GE Healthcare; and her institution has received grants from Pfizer and GE Healthcare, all unrelated to the current work. Dr Einstein has received consulting fees from W. L. Gore and Associates; has received fees for lecturing from Ionetix; and his institution has grants/grants pending from Canon Medical Systems, Eidos Therapeutics, GE Healthcare, Roche Medical Systems, W. L. Gore and Associates, and XyloCor Therapeutics, all unrelated to the current work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. (© 2021 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu